Skip to main content

Actors and Networks database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Additional complementary work by other organisations on GCT stakeholders mapping can be found here.

A scientific paper on actors has also been published in Humanities and Social Sciences Communications. You can find its lay summary here.

Showing 10 of 373

Patients' Network for Health and Medical Research (EGAN)

Region/Country:  
  • EU/EEA
Website:  

Type of Actor:

  • Patient Organisations
  • European Patient Organisations

Development Stage:

  • Patient and Public Involvement

Additional information

EGAN - Patients Network for Medical Research and Health - is a dynamic, non-profit collaboration of patient organisations that work together because they recognize the value of their involvement in genetics, genomics and medical biotechnology for the prevention and treatment of genetic, multifactorial and congenital disorders. EGAN is working for a voice in research and health policy and seeks a world in which genetic diseases are understood, effectively treated, prevented and the people affected supported.

Resources

Publications and FAQs: https://egan.eu/publications/; Information on biomedical research: https://egan.eu/biomedical-research/

Paul-Ehrlich-Institut (PEI)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation

Additional information

PEI is an Agency of the German Federal Ministry of Health. Its research and control activities promote the quality, efficacy and safety of biological medicinal products.

Polish Agency for Health Technology Assessment and Tariff System (Agencja Oceny Technologii Medycznych i Taryfikacji) (AOTMiT)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

Polish Chief Pharmaceutical Inspectorate (Główny Inspektorat Farmaceutyczny)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Polish Institute of Hematology and Transfusion Medicine (Instytut Hematologii i Transfuzjologii) (IHT)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Fundamental Research
  • Translational Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Polish Ministry of Climate and Environment (Ministerstwo Klimatu i Środowiska)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Polish Ministry of Health (Ministerstwo Zdrowia)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells

Development Stage:

  • Fundamental Research
  • Translational Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Polish National Blood Centre (Narodowe Centrum Krwi) (NCK)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Manufacturing
  • Commercialisation

Polish National Centre of Tissue and Cell Banking (Krajowe Centrum Bankowania Tkanek i Komrek) (NCTCB)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells

Development Stage:

  • Manufacturing
  • Commercialisation

Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Medical Devices Entities
  • Medical Device Authorities
  • National Medical Device Authorities
  • Other National competent authorities
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts